Altria Aktie News

For some Americans, cigarettes are an essential product, despite the cost of smoking averaging $3,000 per smoker per year.

The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.

Altria has underperformed the S&P 500 in recent years. The stock remains a dividend powerhouse with a yield above 7%.

The September inflation reading of 3% represents moderate price growth, which is above the Federal Reserve's long-term target of 2% but well below the elevated rates seen in 2022 and early 2023.

Altria's annual dividend is $4.24. The company is a Dividend King, with 56 consecutive years of increases.

If you like big, steady income, there are a lot of tempting opportunities that have recently sold off significantly. In particular, this report reviews four distinct big-yield categories, from which Altria's category (well-covered qualified dividends) is arguably the best. After sharing big-yield data and reviewing four specific compelling opportunities (including a deep dive into Altria's busi...

The Dividend Harvesting Portfolio remains up 32.60% on invested capital, yielding 8.02%, despite a temporary dip in dividend income from the MSTY reverse split. A dovish Fed rate cut and bullish GDP projections support expectations for a year-end market rally, favoring income-generating, rate-sensitive holdings. Recent capital was allocated to AMLP for high-yield, fee-based energy exposure, and...

Dividend Kings remain largely overvalued, but six—including MO, UVV, HRL, KVUE, CDUAF, and UBSI—are now fairly priced with yields (from $1k invested) exceeding share prices. Analyst forecasts project net gains of 19.89% to 93.08% for select high-yield Dividend Kings by December 2026, with an average net gain of 34.89%. Only three Dividend Kings—MO, KVUE, UBSI—currently meet both the 'safer' div...